|
|
Volumn 34, Issue 9, 2013, Pages 479-480
|
|
Gardasil administration to hr-HPV-positive women and their partners
a
|
|
Author keywords
cervical cancer; intention to prevent; intention to treat; papillomavirus infection; sexually transmitted infection; vaccination
|
|
Indexed keywords
RECOMBINANT VACCINE;
WART VIRUS VACCINE;
CLINICAL TRIAL (TOPIC);
CONDYLOMA ACUMINATUM;
COST BENEFIT ANALYSIS;
DISEASE ASSOCIATION;
DISEASE CARRIER;
DRUG EFFICACY;
DRUG INDICATION;
GENITAL TRACT INFECTION;
HEALTH CARE COST;
HUMAN;
HUMAN PAPILLOMAVIRUS TYPE 11;
HUMAN PAPILLOMAVIRUS TYPE 16;
HUMAN PAPILLOMAVIRUS TYPE 18;
HUMAN PAPILLOMAVIRUS TYPE 6;
IMMUNE RESPONSE;
INFECTION PREVENTION;
INTENTION TO TREAT ANALYSIS;
LETTER;
MIXED INFECTION;
OFF LABEL DRUG USE;
PAPILLOMAVIRUS INFECTION;
PRIORITY JOURNAL;
PUBLIC HEALTH;
SEROTYPE;
SEXUALLY TRANSMITTED DISEASE;
SUPERINFECTION;
UTERINE CERVIX CANCER;
VACCINATION;
WOMEN'S HEALTH;
CERVICAL CANCER;
INTENTION TO PREVENT;
INTENTION TO TREAT;
PAPILLOMAVIRUS INFECTION;
SEXUALLY TRANSMITTED INFECTION;
VACCINATION;
ALPHAPAPILLOMAVIRUS;
FEMALE;
HUMANS;
MALE;
PAPILLOMAVIRUS INFECTIONS;
PAPILLOMAVIRUS VACCINES;
SEXUALLY TRANSMITTED DISEASES, VIRAL;
|
|
EID: 84883763465
PISSN: 01656147
EISSN: 18733735
Source Type: Journal
DOI: 10.1016/j.tips.2013.07.001 Document Type: Letter |
|
Times cited : (12)
|
|
References (8)
|
